Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses.
Most antiviral treatment options target the invading pathogen and unavoidably encounter loss of efficacy as the pathogen mutates to overcome replication restrictions. A good strategy for circumventing drug resistance, or for pathogens without treatment options, is to target host cell proteins that a...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3983190?pdf=render |
| _version_ | 1819156630577610752 |
|---|---|
| author | Marta J Gonzalez-Hernandez Anupama Pal Kofi E Gyan Marie-Eve Charbonneau Hollis D Showalter Nicholas J Donato Mary O'Riordan Christiane E Wobus |
| author_facet | Marta J Gonzalez-Hernandez Anupama Pal Kofi E Gyan Marie-Eve Charbonneau Hollis D Showalter Nicholas J Donato Mary O'Riordan Christiane E Wobus |
| author_sort | Marta J Gonzalez-Hernandez |
| collection | DOAJ |
| description | Most antiviral treatment options target the invading pathogen and unavoidably encounter loss of efficacy as the pathogen mutates to overcome replication restrictions. A good strategy for circumventing drug resistance, or for pathogens without treatment options, is to target host cell proteins that are utilized by viruses during infection. The small molecule WP1130 is a selective deubiquitinase inhibitor shown previously to successfully reduce replication of noroviruses and some other RNA viruses. In this study, we screened a library of 31 small molecule derivatives of WP1130 to identify compounds that retained the broad-spectrum antiviral activity of the parent compound in vitro but exhibited improved drug-like properties, particularly increased aqueous solubility. Seventeen compounds significantly reduced murine norovirus infection in murine macrophage RAW 264.7 cells, with four causing decreases in viral titers that were similar or slightly better than WP1130 (1.9 to 2.6 log scale). Antiviral activity was observed following pre-treatment and up to 1 hour postinfection in RAW 264.7 cells as well as in primary bone marrow-derived macrophages. Treatment of the human norovirus replicon system cell line with the same four compounds also decreased levels of Norwalk virus RNA. No significant cytotoxicity was observed at the working concentration of 5 µM for all compounds tested. In addition, the WP1130 derivatives maintained their broad-spectrum antiviral activity against other RNA viruses, Sindbis virus, LaCrosse virus, encephalomyocarditis virus, and Tulane virus. Thus, altering structural characteristics of WP1130 can maintain effective broad-spectrum antiviral activity while increasing aqueous solubility. |
| first_indexed | 2024-12-22T15:55:56Z |
| format | Article |
| id | doaj.art-e29f5e9155354f19a94c1fe5eb87bd0c |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-22T15:55:56Z |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-e29f5e9155354f19a94c1fe5eb87bd0c2022-12-21T18:20:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9449110.1371/journal.pone.0094491Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses.Marta J Gonzalez-HernandezAnupama PalKofi E GyanMarie-Eve CharbonneauHollis D ShowalterNicholas J DonatoMary O'RiordanChristiane E WobusMost antiviral treatment options target the invading pathogen and unavoidably encounter loss of efficacy as the pathogen mutates to overcome replication restrictions. A good strategy for circumventing drug resistance, or for pathogens without treatment options, is to target host cell proteins that are utilized by viruses during infection. The small molecule WP1130 is a selective deubiquitinase inhibitor shown previously to successfully reduce replication of noroviruses and some other RNA viruses. In this study, we screened a library of 31 small molecule derivatives of WP1130 to identify compounds that retained the broad-spectrum antiviral activity of the parent compound in vitro but exhibited improved drug-like properties, particularly increased aqueous solubility. Seventeen compounds significantly reduced murine norovirus infection in murine macrophage RAW 264.7 cells, with four causing decreases in viral titers that were similar or slightly better than WP1130 (1.9 to 2.6 log scale). Antiviral activity was observed following pre-treatment and up to 1 hour postinfection in RAW 264.7 cells as well as in primary bone marrow-derived macrophages. Treatment of the human norovirus replicon system cell line with the same four compounds also decreased levels of Norwalk virus RNA. No significant cytotoxicity was observed at the working concentration of 5 µM for all compounds tested. In addition, the WP1130 derivatives maintained their broad-spectrum antiviral activity against other RNA viruses, Sindbis virus, LaCrosse virus, encephalomyocarditis virus, and Tulane virus. Thus, altering structural characteristics of WP1130 can maintain effective broad-spectrum antiviral activity while increasing aqueous solubility.http://europepmc.org/articles/PMC3983190?pdf=render |
| spellingShingle | Marta J Gonzalez-Hernandez Anupama Pal Kofi E Gyan Marie-Eve Charbonneau Hollis D Showalter Nicholas J Donato Mary O'Riordan Christiane E Wobus Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses. PLoS ONE |
| title | Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses. |
| title_full | Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses. |
| title_fullStr | Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses. |
| title_full_unstemmed | Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses. |
| title_short | Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses. |
| title_sort | chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several rna viruses |
| url | http://europepmc.org/articles/PMC3983190?pdf=render |
| work_keys_str_mv | AT martajgonzalezhernandez chemicalderivativesofasmallmoleculedeubiquitinaseinhibitorhaveantiviralactivityagainstseveralrnaviruses AT anupamapal chemicalderivativesofasmallmoleculedeubiquitinaseinhibitorhaveantiviralactivityagainstseveralrnaviruses AT kofiegyan chemicalderivativesofasmallmoleculedeubiquitinaseinhibitorhaveantiviralactivityagainstseveralrnaviruses AT marieevecharbonneau chemicalderivativesofasmallmoleculedeubiquitinaseinhibitorhaveantiviralactivityagainstseveralrnaviruses AT hollisdshowalter chemicalderivativesofasmallmoleculedeubiquitinaseinhibitorhaveantiviralactivityagainstseveralrnaviruses AT nicholasjdonato chemicalderivativesofasmallmoleculedeubiquitinaseinhibitorhaveantiviralactivityagainstseveralrnaviruses AT maryoriordan chemicalderivativesofasmallmoleculedeubiquitinaseinhibitorhaveantiviralactivityagainstseveralrnaviruses AT christianeewobus chemicalderivativesofasmallmoleculedeubiquitinaseinhibitorhaveantiviralactivityagainstseveralrnaviruses |